Portfolio company
Olfera
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Olfera develops biopharmaceutical delivery solutions using an olfactory platform to transport drugs directly to the brain for patients with neurological conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
EnClear Therapies
The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.
Cyrano Therapeutics
The company develops pharmaceutical therapies to restore the sense of smell and taste for patients suffering from long-term olfactory dysfunction.
Infera Neuro
This company develops neural-decoding chips for brain-computer interfaces to restore communication for individuals with speech loss caused by stroke or neurodegenerative disease.
Bexorg
Bexorg provides an AI-powered perfusion platform using post-mortem human brains to facilitate central nervous system drug discovery for pharmaceutical and academic researchers.
IMPL
This biopharmaceutical company develops nasal spray treatments for central nervous system disorders, such as migraines and Parkinson's disease, for patients with high unmet needs.
Biorchestra
The company develops RNA-based medicines and delivery systems for patients with neurodegenerative and rare central nervous system diseases.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
BrainZell
The company develops brain organoid models and computational tools for pharmaceutical firms to discover central nervous system drugs and test their efficacy.
